GPR120 suppresses adipose tissue lipolysis and synergizes with GPR40 in antidiabetic efficacy-Reference-Cited by-同舟云学术

GPR120 suppresses adipose tissue lipolysis and synergizes with GPR40 in antidiabetic efficacy

Published:2017-08 Issue:8 Volume:58 Page:1561-1578
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Satapati Santhosh,Qian Ying,Wu Margaret S.,Petrov Aleksandr,Dai Ge,Wang Sheng-ping,Zhu Yonghua,Shen Xiaolan,Muise Eric S.,Chen Ying,Zycband Emanuel,Weinglass Adam,Di Salvo Jerry,Debenham John S.,Cox Jason M.,Lan Ping,Shah Vinit,Previs Stephen F.,Erion Mark,Kelley David E.,Wang Liangsu,Howard Andrew D.,Shang Jin

Funder

Merck

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference42 articles.

1. Update on cardiovascular safety of PPARgamma agonists and relevance to medicinal chemistry and clinical pharmacology;Ciudin;Curr. Top. Med. Chem.,2012

2. Free fatty acid receptors as therapeutic targets for the treatment of diabetes;Ichimura;Front. Pharmacol.,2014

3. G protein-coupled receptors: signalling and regulation by lipid agonists for improved glucose homoeostasis;Moran;Acta Diabetol.,2016

4. Distribution and regulation of protein expression of the free fatty acid receptor GPR120;Miyauchi;Naunyn Schmiedebergs Arch. Pharmacol.,2009

5. A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice;Oh;Nat. Med.,2014

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GPR40/GPR120 Agonist GW9508 Improves Metabolic Syndrome-Exacerbated Periodontitis in Mice;International Journal of Molecular Sciences;2024-09-05

2. EPA and DHA differentially improve insulin resistance by reducing adipose tissue inflammation—targeting GPR120/PPARγ pathway;The Journal of Nutritional Biochemistry;2024-08

3. Chronic administration of hydrolysed pine nut oil to mice improves insulin sensitivity and glucose tolerance and increases energy expenditure via a free fatty acid receptor 4-dependent mechanism;British Journal of Nutrition;2024-05-16

4. G protein-coupled receptors driven intestinal glucagon-like peptide-1 reprogramming for obesity: Hope or hype?;Biomedicine & Pharmacotherapy;2024-03

5. GPCRs involved in metabolic diseases: pharmacotherapeutic development updates;Acta Pharmacologica Sinica;2024-02-07